Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “HIV Viremia”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableUnknownNCT02354209
What this trial is testing

Targeted Clinical Strategies and Low Level Viraemia (LLV) in Boosted Protease Inhibitor Therapy

Who this might be right for
HIV
St Stephens Aids Trust 50
Post-approval studies (Phase 4)Ended earlyNCT00414284
What this trial is testing

BOOST: Study of Increased Dosage of Lopinavir/Ritonavir (LPV/r)

Who this might be right for
HIV Infections
Community Research Initiative of New England
Large-scale testing (Phase 3)Study completedNCT00051038
What this trial is testing

Study of Adding Entecavir to Current Lamivudine Therapy in HIV and HBV Co-Infected Patients

Who this might be right for
Hepatitis B
Bristol-Myers Squibb
Early research (Phase 1)Study completedNCT00002268
What this trial is testing

A Randomized, Phase I/II Trial to Assess the Safety and Antiviral Effects of Escalating Doses of A Human Anti-Cytomegalovirus Monoclonal Antibody (SDZ MSL-109) in Patients With the Acquired Immunodeficiency Syndrome and CMV Viremia and/or Viruria

Who this might be right for
Cytomegalovirus InfectionsHIV Infections
Sandoz
Post-approval studies (Phase 4)Ended earlyNCT01367210
What this trial is testing

Switch to Darunavir/r + Maraviroc Quaque Die in Patients With R5 Tropism by Viral DNA Genotyping (GUSTA)

Who this might be right for
HIV Infection
Catholic University of the Sacred Heart 165
Not applicableUnknownNCT05377463
What this trial is testing

Optimizing a Bio-behavioral Intervention for Sustained Viral Suppression

Who this might be right for
HIV Viremia
University of Texas, El Paso 220
Testing effectiveness (Phase 2)Study completedNCT01019551
What this trial is testing

Therapeutic Intensification Plus Immunomodulation in HIV-infected Patients

Who this might be right for
HIV-1 Infection
Objectif Recherche Vaccins SIDA 29
Testing effectiveness (Phase 2)Study completedNCT00002663
What this trial is testing

Biological Therapy in Treating Patients at High-Risk or With Lymphoma, Lymphoproliferative Disease, or Malignancies

Who this might be right for
EBV-induced LymphomasEBV-associated MalignanciesTransplant Patients With EBV Viremia at High Risk of Developing a Recurrent EBV Lymphoma
Atara Biotherapeutics 58
Early research (Phase 1)WithdrawnNCT05700630
What this trial is testing

Ph1 Study of FT538 Alone and With Vorinostat for Persistent Low-Level HIV Viremia

Who this might be right for
HIV-1-infectionARTCd4+ Lymphocyte Deficiency+2 more
Masonic Cancer Center, University of Minnesota
Not applicableStudy completedNCT00000911
What this trial is testing

Monitor Patients With Primary or Early HIV Infection

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 1,500
Not applicableWithdrawnNCT03033017
What this trial is testing

Predictors of Time to Viremia With an Analytic Treatment Interruption

Who this might be right for
HIV
University of Minnesota
Not applicableStudy completedNCT03088241
What this trial is testing

"Switch Either Near Suppression Or THOusand"

Who this might be right for
HIV/AIDS
Niklaus Labhardt 80
Not applicableStudy completedNCT00001110
What this trial is testing

Effect of Anti-HIV Therapy (HAART) on HIV Levels in the Lungs and on Lung Cell Inflammation in HIV-Infected Patients

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 50
Testing effectiveness (Phase 2)Study completedNCT00367458
What this trial is testing

Randomized Placebo-Controlled Trial of Atorvastatin in HIV-Positive Patients Not on Antiretroviral Therapy

Who this might be right for
HIV
National Institute of Allergy and Infectious Diseases (NIAID) 24
Not applicableStudy completedNCT04048629
What this trial is testing

Impact of Point-of-care (POC) Viral Load (VL) Testing During Pregnancy in Zimbabwe

Who this might be right for
HIV Infections
Clinton Health Access Initiative Inc. 1,715
Not applicableNot Yet RecruitingNCT07015164
What this trial is testing

Role of Viral Reservoir, Immune Activation and Depletion in Persistent Viremia Persistent Viremia in People Living With HIV on Antiretroviral Therapy

Who this might be right for
HIV
Assistance Publique - Hôpitaux de Paris 80
Post-approval studies (Phase 4)Study completedNCT00114933
What this trial is testing

"OK 2004 Study" (Only Kaletra 2004 Study): Study to Evaluate Suspending Nucleosides From Triple-Drug Therapy in HIV Subjects

Who this might be right for
HIV Infection
Arribas, Jose R., M.D. 200
Post-approval studies (Phase 4)Study completedNCT00662545
What this trial is testing

Entecavir Intensification for Persistent HBV Viremia in HIV-HBV Infection

Who this might be right for
HIV InfectionsHepatitis B
University of California, San Francisco 10
Early research (Phase 1)Active Not RecruitingNCT03374202
What this trial is testing

Safety and Tolerability of AAV8 Delivery of a Broadly Neutralizing Antibody in Adults Living With HIV: a Phase 1, Dose-escalation Trial

Who this might be right for
HIV-1 Infected Adults With Controlled Viremia
National Institute of Allergy and Infectious Diseases (NIAID) 10
Large-scale testing (Phase 3)Study completedNCT01034917
What this trial is testing

Switching From Protease Inhibitor (PI) to Etravirine in HIV-1 Infected Subjects With Viremia Suppression

Who this might be right for
HIV
Germans Trias i Pujol Hospital 43
Next Page